Recently, p73, a new member of the p53 family, has been cloned and mapped t
o chromosome 1p36, a region that is frequently deleted in a variety of huma
n cancers. p73 can activate p53-responsive promoters and induce apoptosis w
hen overexpressed in certain p53-deficient tumor cells, In contrast to p53,
analysis of the p73 gene in several human solid tumors did not reveal loss
of p73 expression or mutations in the p73 gene, However, transcriptional s
ilencing of the p73 gene by hypermethylation of a CpG island was observed i
n several leukemias and lymphomas, These lymphoid neoplasms also show incre
ased expression of vascular endothelial growth factor (VEGF), an endothelia
l cell-specific mitogen and a key mediator of angiogenesis, To evaluate a p
ossible relationship between p73 status and VEGF expression, we have studie
d the effect of ectopically expressed p73 on the regulation of the VEGF gen
e, Our results demonstrate that p73 can down-regulate endogenous VEGF gene
expression on mRNA and protein level. This effect is mediated by transcript
ional repression of the VEGF promoter and involves the promoter region -85
to -50 bp, containing a cluster of Sp 1 binding sites. Our results suggest
a regulatory role for p73 in tumor angiogenesis.